Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1
Information source: National Institute on Drug Abuse (NIDA)
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cocaine-Related Disorders; Substance-Related Disorders
Intervention: Desipramine (Drug)
Phase: Phase 2
Status: Completed
Sponsored by: National Institute on Drug Abuse (NIDA) Official(s) and/or principal investigator(s):
Frank Gawin, M.D., Principal Investigator, Affiliation: Friends Research Institute, Inc.
Summary
The purpose of this study is to confirm whether a blood level ""ceiling"" exists on
desipramine effect in cocaine abuse.
Clinical Details
Official title: Evaluation of a Desipramine Ceiling in Cocaine Abuse
Study design: Treatment
Primary outcome: CravingRetention Cocaine use Depression Anxiety Mood indicators
Eligibility
Minimum age: 18 Years.
Maximum age: 65 Years.
Gender(s): Both.
Criteria:
Please contact site for information.
Locations and Contacts
Friends Research Institute, Los Angeles, California 90025, United States
Additional Information
Starting date: May 1994
Ending date: December 2001
Last updated: August 16, 2005
|
